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The proinﬂammatory cytokines of TNF-α and IL-1β have been reported to be
increased in gastric mucosal surfaces in people with Helicobacter pylori infection.
Accordingly, this study was conducted to investigate the relationship between the
presence of H. pylori genes and the serum oscillations of these cytokines. In this study,
DNA was ﬁrst extracted from the stool samples of infected individuals and used as
DNA template to investigate the presence of glmM and 16S rRNA genes in PCR. The
ELISA assay was employed to examine serum levels of TNF-α and IL-1β cytokines.
According to statistical analysis, there was a signiﬁcant correlation between the
presence of glmM and 16S rRNA genes in the stool samples of infected persons and
the serum oscillations of TNF-α and IL-1β cytokines. At the end of study and analysis
of the data in case group with HPSAg+, 47.6% of the glmM gene and 23.6% of the 16S
rRNA gene were positive. In addition, a signiﬁcant correlation was observed between
the presence of glmM and 16S rRNA genes in the stool specimens of infected
individuals and the serum levels of TNF-α and IL-1β cytokines (p< 0.05). Consider-
ing the results, it can be concluded that ﬂuctuations in the amount of HPSA, TNF-α,
and IL-1β in H. pylori infection depend on the presence of glmM and 16S rRNA genes.
The presence of glmM and 16S rRNA in the stool sample increases by boosting the
response level to stool antigen (HPSA), IL-1β, and TNF-α, suggesting the prognosis of
the disease with a bacterial virulence form using stool tests.
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Introduction
Helicobacter pylori are spiral-shaped, Gram-negative, microaerophilic
bacteria with ﬂagella that develop gastritis, gastric ulcer, and gastric adenocarci-
noma, as well as are associated with primary gastric lymphoma and expansion
within the glandular epithelium [1, 2]. H. pylori infection often constantly
causes chronic swelling, but only some of the Helicobacter strains can create
ulcer more than the others. However, the nature of immune response may indicate
different consequences of the infection by this organism [3]. Several previous
studies on the patient with H. pylori infection reported an increase in the
proinﬂammatory cytokines of TNF-α, IL-1β, IL-1RN, IL-8, and IL-10 in gastric
mucosal surfaces [4, 5].
TNF-α is the main mediator of acute inﬂammatory responses to
Gram-negative bacteria and other infectious microbes and responsible for many
common complications of acute generalized infections. The lipopolysaccharide
(LPS) in the cell wall of the Gram-negative bacteria is the strongest stimulant of
TNF-α production by macrophages. The key physiological action of TNF is to
recruit the neutrophils, monocytes, and macrophages toward the infection site and
activation of these cells [6]. TNF, similar to IL-1, affects the cells that regulate the
body temperature in the hypothalamus [6].
IL-1β is a proinﬂammatory cytokine caused by H. pylori infection and a
strong inhibitor of gastric acid secretion. This proinﬂammatory cytokine has
an afﬁnity for colonization of H. pylori and consequently exacerbation of
gastric inﬂammation [7]. Studies have shown that IL-1β-31 and IL-1β-511
polymorphisms are associated with high production of IL-1β and develop
gastric cancer [8, 9].
The main function of IL-1β, like TNF-α, is to participate in host inﬂamma-
tory responses to infection and other inﬂammatory stimuli. The IL-1β secretion in
large amounts and then penetration into the bloodstream result in endocrine action
and generally along with TNF induce fever, synthesize the acute-phase proteins in
the liver, and lead to metabolic weakness [6].
In the process of developing the disease by H. pylori, this bacterium can be
established for many years in the stomach, and it affects the patient’s immune
system, resulting in the induction of inﬂammation in the gastric mucosa.
This chronic inﬂammatory response recruits neutrophil, followed by T- and
B-lymphocytes and macrophages to the inﬂammatory site. The immune response
stimulated in the affected area causes inﬂammation and tissue damage due to the
release of inﬂammatory mediators, such as TNF and IL-1 cytokines, as well as
the free radicals of NO and O [10]. With continued process, the chronic gastritis is
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created. These conditions in different patients may lead to gastric atrophy,
intestinal metaplasia, or gastric cancer, depending on virulence factors, host
genetic factors and, as previously stated, the host immune system that differs in
various races [11].
Considering the extent of the ﬁnancial and life-threatening losses
associated with this bacterium, particularly the major cause of gastrointestinal
cancers, the development of the study will be very valuable in this regard.
Considering the number of patients with gastrointestinal problems in Ilam
province (Iran), as well as the fact that gastritis is one of the stages prior to
cancer in people with gastrointestinal problems, it seems that the information
on the secretion of cytokines and their relationship with bacterial virulence and
antigenic factors (LPS) could be exploited to diagnose and to accurately
understand the relevant mechanisms and factors associated with the disease for
screening and preventing at the higher levels. Therefore, this study was
designed to investigate the presence of glmM and 16S rRNA genes of
H. pylori in the infected patients and their relation with serum levels of
TNF-α and IL-1β cytokines.
Materials and Methods
This case–control study was performed on 84 patients with gastrointesti-
nal complaints referring to medical diagnostic laboratories in Ilam. The case
group consisted of the subjects with positive rapid H. pylori stool antigen
(HPSAg+) and the control group had negative HPSAg test (HPSAg). Demo-
graphic characteristics of the subjects (age, sex, occupation, and education)
were recorded in the designed questionnaire. The study objectives were
explained and the consent of the individuals was drawn to participate in the
study, then the blood and stool samples were taken and sent to the Immunology
Laboratory of Ilam University of Medical Sciences for conducting the tests
and studies.
DNA extraction and polymerase chain reaction (PCR)
The DNA was extracted from all stool specimens using DNA extraction kit
(CinnaGen Co., Iran), concentrated in ethanol, and stored at −20 °C in freezer.
PCR was used to investigate the presence of glmM and 16S rRNA genes. For this
purpose, speciﬁc primers were designed for these genes using IDALLEL version 5
Software (Table I).
RELATIONSHIP BETWEEN TNF-α AND IL-1β WITH GLMM AND 16S rRNA GENES 491
Acta Microbiologica et Immunologica Hungarica 65, 2018
The target DNA ampliﬁcation with a ﬁnal volume of 25 μl contained 12 μl of
prepared master mix (Ampliqune, Finland), 7 μl of sterilized double-distilled
water, 1.5 μl of each of the forward and reverse primers, and ﬁnally, 3 μl of the
DNA template (DNA extracted from the stool samples), which was poured into
0.2-micron microtubes, vortexed, and then transferred into a thermal cycler device.
The speciﬁc temperature conditions for each of these genes were adjusted after
complete setup (Table II).
At the end of the PCR process, electrophoresis was performed to observe the
results and determine the presence of glmM and 16S rRNA genes in the PCR
product. In this way, 7 μl of the PCR product was transferred into the wells of 1%
agarose gel containing DNA safe stain immersed in an electrophoresis tank with
TAE (TAE buffer is a buffer solution containing a mixture of Tris base, acetic acid
and EDTA) 1×, which was then exposed to electric current at 85 V for 85 min.
Then, Gel Doc was used to observe and take images (Figure 1).
Enzyme-linked immunosorbent assay (ELISA)
The serum of all blood samples from the participants was separated with the
help of speciﬁc kits (Bosterbio Company: Antibody and ELISA Experts, Plea-
santon, CA) to measure the levels of TNF-α and IL-1β cytokines using ELISA
reader device, according to the manufacturer’s instructions.
All the results were analyzed by SPSS software using Kolmogorov–
Smirnov test, one-way analysis of variance, Kruskal–Wallis test, and logistic
regression. A p value of <0.05 was considered as a signiﬁcance level.
Table I. Speciﬁc primers used for polymorphism analyses
Gene Primer Sequence (5′→3′) Product PCR (bp)
glmM F ACCCGATATTGTTCGAC 224
R GCGAATATACGCGGTTA
16s rRNA F CAATGGCTATACCTAC 521
R GATGGAATTAGCCTTACG
Note: F: forward; R: reverse; PCR: polymerase chain reaction.
Table II. Speciﬁc temperature schedule for primers
Gene Hot start Denaturation Annealing Extension Final extension
glmM 95 °C, 5 min 94 °C, 1 min 51 °C, 1 min 72 °C, 1 min 72 °C, 10 min
16s rRNA 95 °C, 5 min 94 °C, 1 min 55 °C, 1 min 72 °C, 1 min 72 °C, 10 min
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Results
At the end of the study and analysis of the data in the case group with
HPSAg+, 47.6% of the glmM gene and 23.6% of the 16S rRNA gene were
positive. In this study, 45.3% of the subjects were women with the mean age of
44.3 years and 54.7% were men with the mean age of 50.2 years. The frequency of
glmM gene in the stool sample of the men and women groups was 23.8%, but the
frequency of 16S rRNA gene was observed to be 14.3% in men and 9.5% in
women.
To evaluate the mean age, the subjects were divided into four age groups
between 4–90 years, such as 4–10, 11–20, 21–49, and 50–90 years; the most
frequent presence of glmM and 16S rRNA genes in stool DNA samples was
observed in the age group of 21–49 years (Table III).
It should also be noted that the frequency of people infected with H. pylori
and subsequently the frequency of glmM and 16S rRNA genes were higher in the
Figure 1. Image of 1% agarose gel with 521 bp bands of 16s rRNA gene and 224 bp bands of glmM
gene. M: Marker 100–3,000 bp; S1 and g2 are samples
Table III. Study of the age group of the subjects
Genes
Age group
4–10 years 11–20 years 21–49 years 50–90 years
glmM (%) – 24 40.5 4.8
16s rRNA (%) 2.4 – 19 2.4
RELATIONSHIP BETWEEN TNF-α AND IL-1β WITH GLMM AND 16S rRNA GENES 493
Acta Microbiologica et Immunologica Hungarica 65, 2018
illiterate and semiliterate groups than in other groups with higher educational
level.
Studying the serum levels of TNF-α and IL-1β proinﬂammatory cytokines
showed that the most frequency of individuals with serum IL-β1 higher than the
cutoff point (9 pg/ml) was observed in the samples positive for glmM and 16S
rRNA genes in stool DNA.
According to statistical analysis, there was a signiﬁcant correlation between
the presence of glmM and 16S rRNA genes in the stool of infected persons and the
serum oscillations of TNF-α and IL-1β cytokines (p< 0.05).
As seen at ﬁrst glance, people who were positive in stool DNA for each of
these two genes, the level of these cytokines was signiﬁcantly higher than those in
other study group (Table IV).
Discussion
According to the World Health Organization, approximately 50% of adults
in developed countries and about 90% of adults in developing countries are
suffering from H. pylori infection [2]. In developing countries, 70%–80% of
children under the age of 15 years are infected with this bacterium. Low
socioeconomic areas have pivotal role in transmitting this infection [12].
The results of many studies suggest that the prevalence of H. pylori is more
common in men than in women [13–15]. In other studies, the contradictory
ﬁndings are also evident [16, 17]. In this study, the frequency of female patients
was more than that of male patients.
The mean age group was between 40 and 60 years old [14, 17–19]. Based on
our analysis, the mean age of infected individuals was 42.3 years. However, there
was no signiﬁcant relationship between glmM gene and age.
Measurement of serum levels of TNF-α and IL-1β cytokines in the study
population revealed that the secretion of these cytokines in individuals positive for
glmM and 16S rRNA genes was signiﬁcantly higher than the negative ones in terms
Table IV. Evaluation of serum levels of IL-1β and TNF-α cytokines with the presence of glmM and 16s
rRNA genes
Variable
glmM 16s rRNA
− + − +
TNF-α 140.8 465.3 109.8 387.4
Cutoff 81
IL-1β 18.2 74.4 19.1 43.6
Cutoff 9
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of the presence of the gene in the stool DNA specimen, suggesting importance of
the role of these genes in stimulating the immune system.
In the previous studies, the stool antigen test was introduced as a low-cost
and rapid diagnostic method with high sensitivity and speciﬁcity for the diagnosis
of H. pylori infection in children [18, 20–22]. We used this non-invasive
diagnostic test as a golden standard for detecting the presence of infection in
this study.
Reports have shown that increased proinﬂammatory cytokines may affect
the pathological process of H. pylori infection [23, 24]. TNF-α can be found in
chronic inﬂammatory conditions. It has been indicated that H. pylori secretes a
19-kDa protein (Tip) inducing TNF-α that can bind to DNA to enhance the
expression of the TNF-α cytokine in the stomach [25].
In this study, there was no statistically signiﬁcant difference in the serum
levels of IL-1β and TNF-α with demographic variables, but the mean difference of
these immune factors was signiﬁcant in case and control groups. There was no
statistically signiﬁcant relationship between sex and these cytokines, but the
means of IL-1β and TNF-α were higher in men than in women.
In a study on serum levels of circulating IL-6 and TNF-α in the patients
with H. pylori infection, no statistically signiﬁcant differences were
observed between serum levels of TNF-α and the sex and age in positive and
negative H. pylori groups [26], which is consistent with this study. The results of
this study and a study by Van demonstrated that this pathogen does not
signiﬁcantly alter the level of TNF-α [26], while the data from this study
indicated an increase in serum levels of IL-1β and TNF-α cytokines in H.
pylori-infected individuals. In another study, the mean level of these two
cytokines in the H. pylori-infected group was signiﬁcantly higher than in
non-infected individuals [25].
According to the reported data on IL-1β and TNF-α cytokines, it is expected
that in people with high levels of HPSA response, especially in chronic conditions,
the rate of these cytokines or their mean, as well as the frequency of people with
high levels of IL-1β and TNF-α in the case group, is greater than the control group.
This is well documented in this research, because the mean level of these cytokines
in the case group was about 1.5–2 times more than the mean in the control group.
However, it is also worth pointing out that increased levels of these cytokines have
been observed in the ages of 21–50 years.
PCR is known as a high-sensitivity method, which can detect the low count
of H. pylori present in the sample, including stool specimens (with a success rate
of 25%–100%) [27]. In general, the difference in the detection rate of H. pylori in
the stool sample is due to the destruction of the bacteria in the intestinal tract or the
presence of inhibitors such as complex polysaccharides as well as the low
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concentration of bacteria in the stool. In recent studies, the sensitivity of this
method varied from 21% to 65.22% [28, 29].
One of the interesting ﬁndings in this research is the association between the
PCR results of stool having glmM and 16S rRNA genes and TNF-α and IL-1β
variables and HPSAg test, which is of high clinical signiﬁcance in diagnosis. This
suggests that the presence of glmM gene in the stool elevates by 2.8 times more
with the increase of each unit of the HPSA test and enhances 1.1 times more with
the increase of each unit of IL-1β cytokine in the serum of patients infected with
H. pylori (Table V).
Moreover, the probability of the presence of 16S rRNA gene in the stool
increases to 2.98 times more with the increase of each unit of the HPSA test and up
to 1.01 times more with the increase in each unit of TNF-α cytokine in the serum
of patients infected with H. pylori (Table VI).
Table V. Correlation of glmM gene with variables HPSA, TNF-α, and IL-1β
B SE Wald df Sig. Exp(B)
Step 1a HpSA 1.032 0.310 11.054 1 0.001 2.806
IL-1β 0.095 0.032 8.618 1 0.003 1.100
TNF-α 0.004 0.004 1.323 1 0.250 1.004
Constant −5.253 1.228 18.307 1 0.000 0.005
Note: Assuming meaningful sig.<0.05 or p< 0.05. B: coefﬁcient for the constant (also called the
“intercept”) in the null model; SE: standard error around the coefﬁcient for the constant; Wald: the Wald
χ2 test that tests the null hypothesis that the constant equals 0; df: degrees of freedom for the Wald χ2 test;
Sig: sig is the p value that measures the signiﬁcance of the coefﬁcient; Exp(B): the exponentiation of the B
coefﬁcient, which is an odds ratio.
aVariables entered on Step 1: HpSA, IL-1β, and TNF-α.
Table VI. Correlation of 16s rRNA gene with variables HPSA, TNF-α, and IL-1β
B SE Wald df Sig. Exp(B)
Step 1a HPSA 1.094 0.366 8.941 1 0.003 2.987
IL-1β −0.035 0.027 1.722 1 0.189 0.965
TNF-α 0.010 0.004 6.235 1 0.013 1.010
Constant −5.493 1.400 15.406 1 0.000 0.004
Note: Assuming meaningful sig. <0.05 or p< 0.05. B: coefﬁcient for the constant (also called the
“intercept”) in the null model; SE: the standard error around the coefﬁcient for the constant; Wald: the
Wald χ2 test that tests the null hypothesis that the constant equals 0; df: degrees of freedom for the Wald χ2
test; Sig: sig is the p value that measures the signiﬁcance of the coefﬁcient; Exp(B): the exponentiation of the
B coefﬁcient, which is an odds ratio.
aVariables entered on Step 1: HpSA, IL-1β, and TNF-α.
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Conclusions
According to the ﬁndings, we can say that the oscillations of HPSA, TNF-α,
and IL-1β tests depend on the presence of H. pylori infection and thus glmM
and 16S rRNA genes. The presence of glmM and 16S rRNA in the stool increases
by boosting the response level to stool antigen (HPSA), IL-1β, and TNF-α.
This suggests the prognosis of the disease with the bacterial virulence form using
stool tests.
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